Recombinant Human DSG3 Protein (HEK293)，His

DSG3 (Desmoglein 3) is a crucial member of the desmosome family of cell adhesion molecules, primarily expressed in keratinocytes, which play a significant role in maintaining the integrity of epithelial tissues. Disorders associated with DSG3, particularly pemphigus vulgaris, an autoimmune blistering disease, highlight its importance in cell-cell adhesion. In pemphigus vulgaris, autoantibodies target DSG3, disrupting the normal adhesion between skin cells and leading to severe blistering of the skin and mucous membranes. The study of recombinant DSG3 proteins has gained traction as researchers aim to better understand the molecular mechanisms underlying the pathogenesis of pemphigus and to explore potential therapeutic strategies. Recombinant proteins offer a platform for investigating the structural and functional aspects of DSG3, including its interactions with antibodies in pemphigus vulgaris. Furthermore, these proteins can be utilized to develop diagnostic tools and therapeutic agents, including the potential for immunomodulatory treatments. As research progresses, the insights gained from DSG3 recombinant proteins may pave the way for innovative approaches to manage autoimmune conditions linked to desmosomal defects and may provide broader implications for understanding cell adhesion and tissue integrity in various diseases.